TABLE 2.

Summary of Patient-Specific (3D-RD) Tumor Dosimetry

153Sm-EDTMP treatment	Patient no.	Tumor no.	Tumor mass (g)	Mean absorbed dose (Gy)	Mean biologically effective dose (Gy)	Equivalent uniform dose (Gy)	Percentage tumor volume reduction	Overall treatment response
Low administered activity	1	1	65.2	1.80	1.81	1.22	−56.4	Progressive disease
	2	1	210	14.6	15.1	3.87	−95.2	Progressive disease
		2	10.9	1.48	1.48	0.98	−218
	3	1	633	2.06	2.06	1.50	−19.5	Progressive disease
	4	1	482	2.85	2.88	2.30	−73.6	Progressive disease
	5	1	43.2	5.45	5.50	3.90	−195	Progressive disease
		2	25.1	3.18	3.16	2.06	−66.7
High administered activity	1	1	132	4.93	5.06	3.25	NA	Progressive disease
	2	1	379	59.3	87.3	12.3	10.7	Stable disease
		2	20.6	21.9	32.2	6.76	36.4
		3	18.3	28.4	35.9	8.29	33.8
		4	21.6	28.6	45.5	5.88	10.5
	5	1	266	21.6	22.3	9.17	−21.0	Stable disease
		2	36.3	23.8	24.7	8.42	38.2
	6	1	25.1	2.93	2.96	1.89	NA	Progressive disease
		2	15.0	3.09	3.13	2.30	NA
		3	23.6	3.13	3.15	2.16	NA
		4	18.0	5.45	5.62	2.32	NA
		5	41.4	3.33	3.35	1.95	NA

NA = not available.